v3.25.4
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2025
STOCK - BASED COMPENSATION  
STOCK-BASED COMPENSATION
13.STOCK-BASED COMPENSATION

2021 Phantom Restricted Share Plan

The Company maintained a cash-based executive compensation plan for certain employees. The Company’s board of directors awarded 1,433,500 interests in the plan (“units”). Each unit represents an unfunded and unsecured right, subject to certain conditions as set forth by the plan. One-third of the units granted to any holder will vest on each of the first, second, and third anniversaries of March 18, 2021 during the term of such holder’s employment with the Company. Payment of a holder’s vested balance is dependent upon a transaction or series of related transactions constituting a qualifying exit event, as defined by the executive compensation plan.

On March 9, 2022, the Company’s board of directors modified the performance condition, specifically the definition of a qualifying exit event. In addition, the board of directors approved the settlement of vested and unvested units in common stock rather than cash, which resulted in a change in classification of the outstanding units from liability to equity. As a result, modification of the units occurred on March 9, 2022 with a grant date fair value of $23.45, the closing stock price of the Company on the date of modification.

Compensation cost related to phantom awards was $0, $552 and $4,371 for the years ended December 31, 2025, 2024 and 2023, respectively, and is recorded in selling, general, and administrative expense. As of December 31, 2024, there were no remaining awards outstanding.

2021 Stock Incentive Plan

In November 2021, we adopted the 2021 Stock Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of incentive stock options to our employees and any parent and subsidiary companies’ employees, and for the grant of non-statutory stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights (“SARs”), performance units, and performance shares to our employees, directors, and consultants and our parent and subsidiary companies’ employees and consultants. As of December 31, 2025, 8,692,050 shares of common stock were reserved and available for issuance under the 2021 Plan.

Performance Awards

On November 4, 2021, the Company issued and granted to certain employees a total of 2,600,000 RSUs under the 2021 Plan, of which 2,250,000 will vest upon satisfaction of a market condition and 350,000 will vest upon satisfaction of a market and service condition. The market condition was defined as the Fair Market Value (as defined in the Plan) of the Company’s common stock shall have equaled or exceeded $40.00 per share for twenty consecutive trading days on or before November 8, 2031. The fair value of the performance awards grant has been estimated as of the date of grant using the Monte-Carlo pricing model with the assumptions below.

2021

Number issued

2,600,000

Vesting period

$40.00 stock price target

Grant price (per share)

$4.65

Dividend yield

0.0%

Expected volatility

32.08%

Risk-free interest rate

1.59%

Expected term (years)

5.67

Weighted average fair value (per share)

$4.65

A summary of our performance awards activity for the year ended December 31, 2025 is as follows:

Weighted Average 

Grant Date

Shares

Fair Value

Outstanding at December 31, 2024

2,600,000

 

$

4.65

Granted

 

Vested

 

(2,250,000)

 

4.65

Forfeited

 

 

Outstanding at December 31, 2025

350,000

 

$

4.65

The market condition was satisfied on November 20, 2025, resulting in the acceleration of unrecognized compensation cost related to the portion of performance awards containing a market condition only. The remaining unvested performance awards will be ratably expensed through the explicit service period ending November 8, 2026. Compensation cost related to performance awards was $5,074, $2,138 and $2,132 for the years ended December 31, 2025, 2024 and 2023 and is recorded in selling, general, and administrative expense. As of December 31, 2025, there was $276 of unrecognized compensation cost related to unvested performance awards, which is expected to be recognized over a weighted-average period of 0.9 years.

Stock Options

Stock options granted under the 2021 Plan are non-qualified and are granted with an exercise price equal to the market value of the Company’s common stock on the date of grant, and vest from one to three years from the date of grant. Stock options are granted with ten-year terms. We recorded compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. The model uses various assumptions, including a risk-free interest rate, the expected term of the options, the expected stock price volatility, and the expected dividend yield. 

The fair value of each option grant has been estimated as of the date of grant with the following assumptions:

2025

2024

2023

Number issued

381,220

328,474

395,253

Vesting period

1 - 3 years

1 - 3 years

1 - 3 years

Grant price (per share)

$32.77 - $34.91

$34.66

$20.53

Dividend yield

1.09% - 1.16%

1.01%

1.56%

Expected volatility

28.50% - 28.73%

28.70%

31.40%

Risk-free interest rate

3.96% - 4.19%

4.36%

3.68%

Expected term (years)

4.68 - 6.00

4.68 - 6.00

4.68 - 6.00

Weighted average fair value (per share)

$10.88

$8.13

$6.34

A summary of our stock option activity for the year ended December 31, 2025 is as follows:

Weighted 

Aggregate

Weighted Average 

Average 

Intrinsic

Remaining Contractual

Options

Exercise Price

Value

Life (in years)

Outstanding at December 31, 2024

1,088,108

 

$

25.81

 

$

7,839

8.2

Granted

 

381,220

34.55

 

Exercised

 

(141,662)

 

23.68

 

2,577

 

Forfeited

 

 

 

 

Outstanding at December 31, 2025

1,327,666

 

$

28.55

 

$

16,323

7.8

Exercisable at December 31, 2025

709,898

$

25.31

$

11,025

7.1

Vested and expected to vest at December 31, 2025

1,327,666

 

$

28.55

 

$

16,323

7.8

Compensation cost related to stock options was $3,248, $2,841 and $1,619 for the years ended December 31, 2025, 2024 and 2023 and is recorded in selling, general, and administrative expense. As of December 31, 2025, there was $4,096 of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 1.8 years.

Restricted Stock Units

Restricted stock units generally vest in either three equal installments over a three-year period or cliff vest after a three-year period from the date of grant and have a grant date fair value of the Company’s closing stock price on the date of grant.

A summary of our RSU activity for the year ended December 31, 2025 is as follows:

Weighted Average 

Grant Date

Shares

Fair Value

Outstanding at December 31, 2024

264,555

 

$

29.11

Granted

 

130,523

34.91

Vested

 

(88,600)

 

26.22

Forfeited

Outstanding at December 31, 2025

306,478

 

$

32.41

Compensation cost related to RSUs was $3,913, $2,816 and $1,267 for the years ended December 31, 2025, 2024 and 2023 and is recorded in selling, general, and administrative expense. As of December 31, 2025, there was $5,655 of unrecognized compensation cost related to RSUs, which is expected to be recognized over a weighted-average period of 1.8 years.